Our Mission & Story
- Reduce Cost
- Increase Access
- Promote Health
A Mission Born of Frustration
The system was broken. Across the country, patients—especially those managing chronic conditions like glaucoma—were routinely struggling with oversized eyedrops that wasted medication, drained their wallets, and created unnecessary anxiety.
It was this widespread barrier-to-care that inspired Dr. Allisa Song. She recognized the profound emotional and financial toll this waste was having on real people. This wasn't just a medical problem; it was a human one.
To solve it, Dr. Song partnered with award-winning engineers Elias Baker and Mackenzie Andrews. Together, they founded Nanodropper to drive a simple, yet powerful, change: put the patient back at the center of eye care.
Our innovative solutions are designed to make sure you get the optimal dose, every single time. This means less waste, less worry, and more access to the medication you need. Today, the Nanodropper is trusted by tens of thousands of doctors and patients. We are dedicated to merging rigorous evidence-based medicine with an empathy-first approach to make eye health accessible for everyone. This is the quality of care you deserve.
More about Dr. Allisa Song
Allisa Song, MD, is the physician-founder and CEO of Nanodropper, a medical device company offering high-value solutions to adherence barriers in eye disease management. Dr. Song received her MD at Mayo Clinic and degrees in Psychology and Biology at University of Washington. She is a peer-reviewed author in the fields of neuroscience, plastic surgery, and ophthalmology and is driven by her passion to create patient-centered solutions to close health equity gaps in the delivery of care.
Her work has been recognized as a Collegiate Inventor by the National Inventors Hall of Fame, Forbes 30 under 30, and Worthy 100.
Clinical Evidence
Backed by Science, Designed for Patients
Nanodropper isn’t just a good idea — it’s been rigorously studied in multiple clinical trials and published in leading ophthalmology journals. Independent researchers and doctors have tested the Nanodropper adaptor in both children and adults, across different eye conditions and medications.
What the Research Shows
Same Results, Smaller Drops
Studies show that “microdrops” delivered with Nanodropper work just as well as conventional drops for things like pupil dilation and glaucoma treatment.
Fewer Side Effects
Because our drops are smaller, patients experienced less stinging, burning, and bad taste in the mouth — some of the most common complaints with traditional eyedrops
Longer-Lasting Bottles
Clinical trials found that Nanodropper can make a medication bottle last 3x longer, helping patients save money and avoid running out of drops early
Better Adherence, Better Health
By making drops more comfortable and affordable, patients are more likely to stay on track with their treatment plans. In glaucoma studies, Nanodropper users had fewer early bottle exhaustion events and better pressure control over time
Where We’ve Been Published
Our work has been peer-reviewed and published in respected journals including:
Ophthalmology
Clinical Ophthalmology
Medical Devices: Evidence
and Research
And our studies are registered on ClinicalTrials.gov for transparency and scientific integrity.
Why This Matters for You
Every drop matters. With Nanodropper, you can feel confident knowing your treatment is backed by science — and designed to make your daily routine easier, safer, and more affordable.